These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 3872167)

  • 1. Determinants of deoxyadenosine toxicity in hybrids between human T- and B- lymphoblasts as a model for the development of drug resistance in T-cell acute lymphoblastic leukemia.
    Kurtzberg J; Hershfield MS
    Cancer Res; 1985 Apr; 45(4):1579-86. PubMed ID: 3872167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential production of deoxyadenosine by human T and B lymphoblasts.
    Iizasa T; Kubota M; Carson DA
    J Immunol; 1983 Oct; 131(4):1776-9. PubMed ID: 6352803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purine metabolizing enzymes as predictors of lymphoblast sensitivity to deoxyadenosine.
    Mitchell BS; Edwards NL
    J Lab Clin Med; 1984 Sep; 104(3):414-24. PubMed ID: 6147383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
    Bagnara AS; Hershfield MS
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-adenosylhomocysteine catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2'-deoxycoformycin alone and in combination with 9-beta-D-arabinofuranosyladenine.
    Hershfield MS; Kredich NM; Koller CA; Mitchell BS; Kurtzberg J; Kinney TR; Falletta JM
    Cancer Res; 1983 Jul; 43(7):3451-8. PubMed ID: 6601986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
    Fox RM; Kefford RF; Tripp EH; Taylor IW
    Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.
    Seto S; Carrera CJ; Wasson DB; Carson DA
    J Immunol; 1986 Apr; 136(8):2839-43. PubMed ID: 2870121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of three T-lymphoid cell lines with distinct sensitivities to deoxyadenosine plus deoxycoformycin.
    Duan DS; Smith W; Sadée W; Cowan MJ
    Thymus; 1992 Feb; 19(1):1-11. PubMed ID: 1373528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells.
    Wolverton JS; Danks MK; Schmidt CA; Beck WT
    Cancer Res; 1989 May; 49(9):2422-6. PubMed ID: 2539902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cytotoxicity of 2-chloro-2'-deoxyadenosine and 2-bromo-2'-deoxyadenosine on cell growth, clonogenicity, DNA synthesis, and cell cycle kinetics.
    Huang MC; Ashmun RA; Avery TL; Kuehl M; Blakley RL
    Cancer Res; 1986 May; 46(5):2362-8. PubMed ID: 2421877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
    Matsumoto SS; Yu AL; Bleeker LC; Bakay B; Kung FH; Nyhan WL
    Blood; 1982 Nov; 60(5):1096-102. PubMed ID: 6289941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
    Beck WT; Cirtain MC; Lefko JL
    Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
    Kefford RF; Fox RM
    Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the mechanism of activation of 9-beta-D-arabinofuranosyladenine in human lymphoid cells using mutants deficient in nucleoside kinases.
    Verhoef V; Sarup J; Fridland A
    Cancer Res; 1981 Nov; 41(11 Pt 1):4478-83. PubMed ID: 6272978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
    Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of deoxyadenosine plus deoxycoformycin on replicative and repair synthesis of DNA in human lymphoblasts and isolated nuclei.
    Matsumoto SS; Yu J; Yu AL
    J Biol Chem; 1988 May; 263(15):7153-8. PubMed ID: 3259231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal incorporation of 2'-deoxyadenosine into polyadenylate segments of polyadenylated RNA in G1-phase-arrested human T-lymphoblasts.
    Kefford RF; Fox RM; McCairns E; Fahey D; Muscat GE; Rowe PB
    Cancer Res; 1983 May; 43(5):2252-7. PubMed ID: 6187447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.
    Hershfield MS; Kredich NM
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4292-6. PubMed ID: 6254019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.